BASAL CELL CARCINOMA (BCC)
Clinical trials for BASAL CELL CARCINOMA (BCC) explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA (BCC) trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA (BCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy drug could be first defense against advanced skin cancer
Disease control Recruiting nowThis phase 2 trial is testing the drug cemiplimab as a first-line treatment for people with advanced basal cell carcinoma who have not received prior therapy. The study will enroll 34 participants and measure how many patients see their tumors shrink or disappear after six months…
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy aims to treat skin cancers without scarring
Disease control Recruiting nowThis early-phase study tests a combination of blue-light photodynamic therapy (a light treatment that kills cancer cells) and the drug sonidegib for people with multiple basal cell carcinomas. The goal is to see if this approach can effectively treat the cancers while avoiding th…
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE1 • Sponsor: Nathalie Zeitouni • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC